JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 935K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Annaert, W. G.
Right arrow Articles by De Strooper, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Annaert, W. G.
Right arrow Articles by De Strooper, B.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/1999//277 $5.00
The Journal of Cell Biology, Volume 147, Number 2, , 1999 277-294


Original Article

Presenilin 1 Controls {gamma}-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons



Wim G. Annaerta, Lyne Levesqueb, Kathleen Craessaertsa, Inge Dierincka, Greet Snellingsa, David Westawayb, Peter St. George-Hyslopb, Barbara Cordellc, Paul Fraserb, and Bart De Stroopera

a CME/VIB4/KULeuven, Gasthuisberg, B-3000 Leuven, Belgium
b Center for Research in Neurodegenerative Diseases, Department of Medical Biophysics and Medicine (Neurology), University of Toronto, Ontario, Canada, M5S 3H2
c Scios Inc., Sunnyvale, California 94086
Neuronal Cell Biology and Gene Transfer Laboratory, Center for Human Genetics, Flanders Interuniversity Institute for Biotechnology, Gasthuisberg, KULeuven, Herestraat 49, B-3000 Leuven, Belgium.132-16-347181132-16-346227

bart.destrooper{at}med.kuleuven.ac.be

Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42), whereas knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998). Therefore, PS1 function is closely linked to the {gamma}-secretase processing of the amyloid precursor protein (APP). Given the ongoing controversy on the subcellular localization of PS1, it remains unclear at what level of the secretory and endocytic pathways PS1 exerts its activity on APP and on the APP carboxy-terminal fragments that are the direct substrates for {gamma}-secretase. Therefore, we have reinvestigated the subcellular localization of endogenously expressed PS1 in neurons in vitro and in vivo using confocal microscopy and fine-tuned subcellular fractionation. We show that uncleaved PS1 holoprotein is recovered in the nuclear envelope fraction, whereas the cleaved PS fragments are found mainly in post-ER membranes including the intermediate compartment (IC). PS1 is concentrated in discrete sec23p- and p58/ERGIC-53–positive patches, suggesting its localization in subdomains involved in ER export. PS1 is not found to significant amounts beyond the cis-Golgi. Surprisingly, we found that APP carboxy-terminal fragments also coenrich in the pre-Golgi membrane fractions, consistent with the idea that these fragments are the real substrates for {gamma}-secretase. Functional evidence that PS1 exerts its effects on {gamma}-secretase processing of APP in the ER/IC was obtained using a series of APP trafficking mutants. These mutants were investigated in hippocampal neurons derived from transgenic mice expressing PS1wt or PS1 containing clinical mutations (PS1M146L and PS1L286V) at physiologically relevant levels. We demonstrate that the APP-London and PS1 mutations have additive effects on the increased secretion of βA4(1-42) relative to βA4(1-40), indicating that both mutations operate independently. Overall, our data clearly establish that PS1 controls {gamma}42-secretase activity in pre-Golgi compartments. We discuss models that reconcile this conclusion with the effects of PS1 deficiency on the generation of βA4(1-40) peptide in the late biosynthetic and endocytic pathways.

Key Words: Alzheimer's disease • presenilin 1 • APP processing • hippocampal neuron • {gamma}-secretase



© 1999 The Rockefeller University Press

1.used in this paper: βA4, β-amyloid peptide; AD, Alzheimer's disease; APP, amyloid precursor protein; ECL, enhanced chemiluminescence; FAD, familial Alzheimer's disease; IC, intermediate compartment; PS1, presenilin 1; PS1-CTF, PS1 carboxy-terminal fragment; PS1-NTF, PS1 amino-terminal fragment; SFV, Semliki Forest virus; VTC, vesiculotubular complex



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article


J. Cell Biol. 1999 147: 1-2. [Full Text] [PDF]





  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents